is good life tirzepatide legit weight loss expectations A 72-week trial compared the two leading GLP-1 medications in GoodLife Tirzepatide: Program Details and

Simultaneously, by stimulating the GLP-1 receptor, the medication reduces appetite and food intake , leading to weight loss

Retatrutide is a triple-agonist weight loss drug thats currently undergoing clinical trials and is not yet FDA approved

Lastly, for patients with significant high-end metabolic issues, sleep apnea, heart disease, uncontrolled hypertension, or immobility due to high BMI, GLP-1s alone may not be enough

Mounjaro (tirzepatide) is approved in multiple countries, though indications may vary

In Colorado Springs, individuals seeking medical guidance on weight loss can access these benefits and more by consulting Klinic's knowledgeable providers

They have a BMI above 27 with at least one weight-related comorbidity, or a BMI above 30 regardless of comorbidities